Wells Fargo
NUTX

Wells Fargo’s Nutex Health NUTX Stock Holding History

Wells Fargo’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$824K Buy
4,823
+2,706
+128% +$343K ﹤0.01% 4242
2026
Q1 		$201K Sell
2,117
-2,617
-55% -$321K ﹤0.01% 4699
2025
Q4 		$779K Buy
4,734
+2,076
+78% +$275K ﹤0.01% 4152
2025
Q3 		$275K Sell
2,658
-242
-8% -$23.7K ﹤0.01% 4736
2025
Q2 		$361K Buy
+2,900
New +$375K ﹤0.01% 4378
2024
Q2 		– Sell
-21
Closed -$307 – 7289
2024
Q1 		$307 Buy
21
+4
+24% +$80 ﹤0.01% 6396
2023
Q4 		$464 Buy
17
+1
+6% +$31 ﹤0.01% 6401
2023
Q3 		$489 Buy
+16
New +$772 ﹤0.01% 6366
2023
Q2 		– Sell
-314
Closed -$47.6K – 7658
2023
Q1 		$47.6K Buy
+314
New +$63.6K ﹤0.01% 5181
2022
Q4 		– Sell
-3
Closed -$1K – 7632
2022
Q3 		$1K Sell
3
-3
-50% -$1.27K ﹤0.01% 6410
2022
Q2 		$3K Buy
+6
New +$7.07K ﹤0.01% 6202

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Wells Fargo's NUTX Position: Q2 2026 in Review

Wells Fargo increased its Nutex Health (NUTX) stake by 128% in Q2 2026, buying an estimated $343K and bringing the position to 4,823 shares worth $824K. The position accounts for ﹤0.01% of the portfolio, ranked #4242.

Wells Fargo first reported a position in NUTX in Q2 2022 and has held it in 11 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Wells Fargo held 4,823 shares of Nutex Health worth $824K as of Q2 2026.
  • Wells Fargo bought 2,706 Nutex Health shares in Q2 2026, an estimated $343K.
  • Nutex Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4242 holding.
  • Wells Fargo first reported a position in Nutex Health in Q2 2022 and has held it in 11 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.